Caoimhe Cronin

Ms. Caoimhe Cronin

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2024 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Open access
AGAoife Gallagher
Aoife Gallagher
CCCaoimhe Cronin
Caoimhe Cronin
THTessa Ah Heng
Tessa Ah Heng
AMAnne McKiernan
Anne McKiernan
CTCiara Tobin
Ciara Tobin
JWJuan Trujillo Wurttele
Juan Trujillo Wurttele
Anaphylaxis is increasing in recent years, with common triggers in infants being milk and eggs. Currently the mainstay of treatment for milk and/or egg allergy is strict avoidance. Recently new therapies have emerged including stepwise introduction of allergens via a ladder approach. The suitability of infants for the ladders is debated. This study aims to focus on the use of food ladders in children with anaphylaxis to egg or milk. Retrospective review of paediatric patients diagnosed with IgE-mediated milk and/or egg allergy between 2011-2021. Inclusion and exclusion criteria applied. Anaphylaxis defined as per the World Allergy Organisation amended criteria 2020. Data analysis utilised SPSS Version 28. 1552 patient charts reviewed, 1094 excluded (n=458). 70 infants had anaphylaxis at diagnosis (milk n=36, egg n=34). 77.8%-85.2% with anaphylaxis successfully completed the ladder, 88.9-92.9% without anaphylaxis were successful. Children who successfully completed the ladder did so at similar rates. 20.6-50% children presenting with anaphylaxis at diagnosis experienced allergic symptoms during treatment, compared to 17.3-40.7% without anaphylaxis. Reactions were mild, mostly cutaneous and not requiring medical attention. Patients experiencing allergic symptoms while on the ladder were less likely to successfully complete treatment. Milk and egg ladders are a safe and effective way of inducing tolerance in infants, including those with a history of anaphylaxis at diagnosis. There are no obvious predictors for who will experience allergic reactions while on the ladder, however these children are less likely to complete the ladder so parents should be educated in management of mild allergic reactions at home.

14 March 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
CCCaoimhe Cronin
Caoimhe Cronin
YRYukta Ramesh
Yukta Ramesh
CPCarlo De Pieri
Carlo De Pieri
RVRoberto Velasco
Roberto Velasco
JWJuan Trujillo Wurttele
Juan Trujillo Wurttele
IgE-mediated cow’s milk protein allergy (CMPA) is one of the most prevalent food allergies in early childhood. Though the cornerstone of management involves the strict avoidance of milk products while awaiting natural tolerance, research increasingly shows that the rates of resolution are slowing down. Therefore, there is a need to explore alternative pathways to promote tolerance to cow’s milk in pediatric populations. This review aims to combine and appraise the scientific literature regarding the three CMPA management methods: avoidance, the milk ladder, and oral immunotherapy (OIT) and their outcomes in terms of efficacy, safety, and immunological effects. Cow’s milk (CM) avoidance virtually protects against allergic reaction until natural tolerance occurs, with hypoallergenic substitutes available in the market, but accidental ingestion represents the main issue for this strategy. Introduction to baked milk using the milk ladder was designed, with most CMPA patients successfully completing the ladder. Similar to baked milk treatment, many OIT protocols also demonstrated decreased IgE and increased IgG4 levels post protocol, as well as a reduction in wheal size diameter. Though these strategies are shown to be safe and effective in CMPA, future clinical trials should compare the safety and effectiveness of these three management strategies.

17 July 2023 in Clinical and Translational Allergy
Verified
Journal Article
Open access
CCCaoimhe Cronin
Caoimhe Cronin
AMAnne Marie McGinley
Anne Marie McGinley
LFLaura Flores
Laura Flores
AMAnne McKiernan
Anne McKiernan
RVRoberto Velasco
Roberto Velasco
JWJuan Trujillo Wurttele
Juan Trujillo Wurttele

11 July 2024 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
JWJuan Trujillo Wurttele
Juan Trujillo Wurttele
CCCaoimhe Cronin
Caoimhe Cronin
THTessa Ah Heng
Tessa Ah Heng
LFLaura Flores
Laura Flores
AMAnne Marie McGinley
Anne Marie McGinley
JHJonathan Hourihane
Jonathan Hourihane
Background: Complete avoidance of milk is the usual management for IgE‐mediated cow's milk protein allergy (CMPA). A baked milk ladder is a method of dietary advancement therapy in IgE‐mediated CMPA in Ireland, while in Spain, avoidance of milk awaiting natural tolerance acquisition through an oral food challenge (OFC) is employed. The aim of this study was to evaluate the use of dietary advancement therapy using a milk ladder compared with complete avoidance of milk for managing IgE‐mediated CMPA.Methods: This is a retrospective chart review of 371 pediatric patients from the population who have been treated for IgE‐mediated CMPA between 2011 and 2020, with the milk ladder (Ireland) or complete avoidance followed by an OFC (Spain). The main outcome was the introduction of cow's milk.Results: Milk ladder patients were 3.67 times more likely to succeed in comparison with milk avoidance (p < .001). Anaphylaxis during the treatment period occurred in 34 patients in the milk avoidance groups, while three patients in the milk ladder group experienced anaphylaxis due to accidental exposure to milk (p < .001). Failure to complete treatment was associated with a higher skin prick test in the milk avoidance group and a raised specific IgE in the milk ladder group.Conclusion: This is the first study that compares outcomes of dietary advancement therapy to complete avoidance for CMPA management, demonstrating that cow's milk can be successfully and safely reintroduced using dietary advancement therapy using a milk ladder.

9 November 2023 in Clinical & Experimental Allergy
Verified
Journal Article
Open access
THTessa Ah Heng
Tessa Ah Heng
CCCaoimhe Cronin
Caoimhe Cronin
LFLaura Flores
Laura Flores
FMFrancois Meyer
Francois Meyer
MOMeg O'Sullivan
Meg O'Sullivan
JWJuan Trujillo Wurttele
Juan Trujillo Wurttele

1 December 2023 in Allergy
Verified
Journal Article
Open access
MSMeg O' Sullivan
Meg O' Sullivan
MCMargaret Curtin
Margaret Curtin
RFRachel Flynn
Rachel Flynn
CCCaoimhe Cronin
Caoimhe Cronin
JMJames O' Mahony
James O' Mahony
JWJuan Trujillo Wurttele
Juan Trujillo Wurttele
Telehealth is an emerging approach that uses technology to provide healthcare remotely. Recent publications have outlined the importance of supporting the transition to self‐management of adolescents with allergic conditions. However, no synthesis of the evidence base on the use and impact of telehealth interventions for this purpose has been conducted to date. This review achieves these aims, in addition to exploring the language use surrounding these interventions, and their implementation. Four databases were searched systematically. References were independently screened by two reviewers. Methodological quality was assessed using the Mixed Methods Appraisal Tool. A narrative synthesis was undertaken. Eighteen articles were included, reporting on 15 telehealth interventions. A total of 86% targeted adolescents with asthma. Mobile applications were the most common telehealth modality used, followed by video‐conferencing, web‐based, virtual reality and artificial intelligence. Five intervention content categories were identified; educational, monitoring, behavioural, psychosocial and healthcare navigational. Peer and/or healthcare professional interaction, gamification and tailoring may increase engagement. The studies showed positive effects of the interventions or no difference from active controls, in self‐management outcomes such as knowledge, health outcomes such as quality‐of‐life, and economic outcomes such as healthcare utilization. The most common implementation outcomes reported were acceptability, appropriateness, feasibility and fidelity.